DOCSLIB.ORG

Supplementary Table 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table 1 Supplementary Table 1 Comparison of gene expression between glioma cells GL26 and M7 cells (Affymetrix Gene Chip Data) Affymetrix Gene Symbol Description GenBank M7 expression GL26 expression Fold Change Probe identifier 1448754_at Rbp1 retinol binding protein 1, cellular NM_011254 11.9324 3.3762 8.5563 1427262_at Xist inactive X specific transcripts L04961 11.2747 2.8100 8.4647 1448182_a_at Cd24a CD24a antigen NM_009846 11.2867 2.8350 8.4517 1416072_at Cd34 CD34 antigen NM_133654 11.3653 3.1525 8.2128 phospholipase A2, group VII (platelet-activating 1430700_a_at Pla2g7 AK005158 11.3513 3.4443 7.9071 factor acetylhydrolase, plasma) 1448169_at Krt18 keratin 18 NM_010664 10.8594 3.1650 7.6945 protein kinase, cAMP dependent regulatory, 1456475_s_at Prkar2b BB216074 10.3735 2.7149 7.6585 type II beta 1448961_at Plscr2 phospholipid scramblase 2 NM_008880 9.8895 2.2443 7.6452 1448162_at Vcam1 vascular cell adhesion molecule 1 BB250384 11.6707 4.0372 7.6336 epidermal growth factor-containing fibulin-like 1427183_at Efemp1 BC023060 10.5180 2.8966 7.6214 extracellular matrix protein 1 1416953_at Ctgf connective tissue growth factor NM_010217 11.7358 4.1689 7.5669 phorbol-12-myristate-13-acetate-induced protein 1418203_at Pmaip1 NM_021451 10.1483 2.5992 7.5491 1 1424254_at Ifitm1 interferon induced transmembrane protein 1 BC027285 12.2968 4.7747 7.5221 1424800_at Enah enabled homolog (Drosophila) BQ044016 10.6460 3.1525 7.4935 protein kinase, cAMP dependent regulatory, 1438664_at Prkar2b BB216074 9.6444 2.3979 7.2465 type II beta 1420624_a_at Vamp8 vesicle-associated membrane protein 8 NM_016794 10.2295 3.0227 7.2068 1437502_x_at Cd24a CD24a antigen BB560574 9.5990 2.3979 7.2011 1423259_at Id4 inhibitor of DNA binding 4 BB121406 9.6991 2.5612 7.1378 1427263_at Xist inactive X specific transcripts L04961 10.7077 3.5815 7.1263 1433694_at Pde3b phosphodiesterase 3B, cGMP-inhibited AV270888 11.0081 3.9024 7.1057 1436936_s_at Xist inactive X specific transcripts BG806300 11.6030 4.6127 6.9903 1436448_a_at Ptgs1 prostaglandin-endoperoxide synthase 1 AA833146 10.1787 3.1902 6.9886 1421811_at Thbs1 thrombospondin 1 AI385532 10.4176 3.4443 6.9734 1417262_at Ptgs2 prostaglandin-endoperoxide synthase 2 M94967 11.3593 4.3997 6.9596 1416034_at Cd24a CD24a antigen NM_009846 10.5012 3.5815 6.9197 1425964_x_at Hspb1 heat shock protein 1 U03561 11.9221 5.0176 6.9046 KH domain containing, RNA binding, signal 1453317_a_at Khdrbs3 AK014353 9.9713 3.1525 6.8188 transduction associated 3 1456174_x_at Ndrg1 N-myc downstream regulated gene 1 AV309418 11.0931 4.2966 6.7965 1453282_at Cxadr coxsackie virus and adenovirus receptor BE824924 9.6261 2.8966 6.7295 1424051_at Col4a2 collagen, type IV, alpha 2 BC013560 10.5889 3.9364 6.6525 1420991_at Ankrd1 ankyrin repeat domain 1 (cardiac muscle) AK009959 9.5299 2.8966 6.6334 1417263_at Ptgs2 prostaglandin-endoperoxide synthase 2 M94967 9.8853 3.2638 6.6215 1422317_a_at Il1rl1 interleukin 1 receptor-like 1 NM_010743 10.3658 3.7575 6.6083 1419209_at Cxcl1 chemokine (C-X-C motif) ligand 1 NM_008176 9.6688 3.0872 6.5816 1424659_at Slit2 slit homolog 2 (Drosophila) BG963150 9.5009 2.9592 6.5418 1418726_a_at Tnnt2 troponin T2, cardiac NM_011619 11.0835 4.6056 6.4779 1420992_at Ankrd1 ankyrin repeat domain 1 (cardiac muscle) AK009959 9.7801 3.3086 6.4715 1453275_at 2310002L13Rik RIKEN cDNA 2310002L13 gene AK009098 9.5985 3.1525 6.4460 1449254_at Spp1 secreted phosphoprotein 1 NM_009263 12.8838 6.4409 6.4429 1449314_at Zfpm2 zinc finger protein, multitype 2 NM_011766 9.9496 3.5138 6.4358 1455627_at Col8a1 collagen, type VIII, alpha 1 AV292255 11.4760 5.0503 6.4256 solute carrier organic anion transporter family, 1449203_at Slco1a5 NM_130861 9.8406 3.4224 6.4182 member 1a5 glutaminyl-peptide cyclotransferase (glutaminyl 1426622_a_at Qpct BB150720 9.4366 3.0227 6.4139 cyclase) 1420760_s_at Ndrg1 N-myc downstream regulated gene 1 NM_008681 10.7821 4.3893 6.3928 1437360_at Pcdh19 protocadherin 19 BB053591 10.2166 3.8700 6.3466 1422943_a_at Hspb1 heat shock protein 1 NM_013560 12.3877 6.0489 6.3388 1436729_at Afap1 actin filament associated protein 1 AV328634 9.2018 2.9592 6.2427 1460419_a_at Prkcb protein kinase C, beta X59274 9.6599 3.4443 6.2157 1419309_at Pdpn podoplanin NM_010329 10.2286 4.0427 6.1859 1423407_a_at Fbln2 fibulin 2 BF228318 9.8358 3.6503 6.1855 1452035_at Col4a1 collagen, type IV, alpha 1 BF158638 11.9677 5.9119 6.0558 1451501_a_at Ghr growth hormone receptor BC024375 11.6290 5.5812 6.0478 1426910_at Pawr PRKC, apoptosis, WT1, regulator BB398886 10.2616 4.2333 6.0282 1457042_at AI256396 EST AI256396 BB328287 9.2221 3.1972 6.0249 1419086_at Fgfbp1 fibroblast growth factor binding protein 1 U49641 10.2979 4.2966 6.0013 1434442_at Stbd1 starch binding domain 1 BB667844 9.0880 3.0872 6.0008 1439766_x_at Vegfc vascular endothelial growth factor C BB089170 8.5104 2.5612 5.9492 1424759_at Arrdc4 arrestin domain containing 4 BC017528 9.0765 3.1701 5.9064 1452740_at Myh10 myosin, heavy polypeptide 10, non-muscle BQ176159 9.8343 3.9701 5.8642 1434280_at BG976607 11.4138 5.5610 5.8528 1415989_at Vcam1 vascular cell adhesion molecule 1 BB250384 10.3399 4.5566 5.7833 1419123_a_at Pdgfc platelet-derived growth factor, C polypeptide NM_019971 8.7250 2.9526 5.7724 1419431_at Ereg epiregulin NM_007950 8.7081 2.9592 5.7489 carbohydrate (keratan sulfate Gal-6) 1449147_at Chst1 NM_023850 9.8513 4.1035 5.7479 sulfotransferase 1 1424967_x_at Tnnt2 troponin T2, cardiac L47552 10.9178 5.2306 5.6871 solute carrier family 14 (urea transporter), 1428114_at Slc14a1 AW556396 8.6683 3.0227 5.6456 member 1 1432331_a_at Prrx2 paired related homeobox 2 AK019971 8.8554 3.2638 5.5917 1447364_x_at Myo1b myosin IB AA406997 8.7681 3.1972 5.5708 1454788_at Arl4c ADP-ribosylation factor-like 4C BQ176306 10.7358 5.1653 5.5705 sema domain, immunoglobulin domain (Ig), 1449865_at Sema3a NM_009152 9.2677 3.7192 5.5484 short basic domain, secreted, (semaphorin) 3A 1448925_at Twist2 twist homolog 2 (Drosophila) NM_007855 9.6841 4.1392 5.5450 1421134_at Areg amphiregulin NM_009704 10.5867 5.0544 5.5323 1447643_x_at Snai2 snail homolog 2 (Drosophila) BB040443 9.3209 3.8342 5.4867 1423413_at Ndrg1 N-myc downstream regulated gene 1 AI987929 8.7622 3.3086 5.4537 1434447_at Met met proto-oncogene BG060788 9.8573 4.4990 5.3583 1437190_at Styk1 serine/threonine/tyrosine kinase 1 AV375472 9.1846 3.8342 5.3503 1417962_s_at Ghr growth hormone receptor NM_010284 12.1145 6.7709 5.3435 1448990_a_at Myo1b myosin IB AI255256 9.4993 4.1689 5.3304 LON peptidase N-terminal domain and ring 1436200_at Lonrf3 BE956940 9.1870 3.9007 5.2864 finger 3 1423414_at Ptgs1 prostaglandin-endoperoxide synthase 1 BB520073 9.6410 4.3588 5.2822 1449070_x_at Apcdd1 adenomatosis polyposis coli down-regulated 1 BB770932 8.1810 2.9178 5.2632 1428804_at Mfap3l microfibrillar-associated protein 3-like AK017269 9.8742 4.6127 5.2615 sema domain, immunoglobulin domain (Ig), 1420416_at Sema3a NM_009152 8.9806 3.7192 5.2614 short basic domain, secreted, (semaphorin) 3A 1418910_at Bmp7 bone morphogenetic protein 7 NM_007557 8.5618 3.3086 5.2532 1419417_at Vegfc vascular endothelial growth factor C NM_009506 7.9141 2.6628 5.2513 1455145_at Pcdh19 protocadherin 19 BM115577 9.6991 4.4935 5.2056 1417023_a_at Fabp4 fatty acid binding protein 4, adipocyte NM_024406 8.3497 3.1525 5.1971 1423635_at Bmp2 bone morphogenetic protein 2 AV239587 8.3322 3.1440 5.1882 brain abundant, membrane attached signal 1428572_at Basp1 AK011545 10.6935 5.5301 5.1634 protein 1 1424890_at Bnc1 basonuclin 1 U88064 8.4060 3.2638 5.1423 ArfGAP with coiled-coil, ankyrin repeat and PH 1434873_a_at Acap1 BB115902 9.7031 4.5648 5.1383 domains 1 cysteine rich transmembrane BMP regulator 1 1426951_at Crim1 AK018666 8.5656 3.4443 5.1213 (chordin like) 1422053_at Inhba inhibin beta-A NM_008380 10.4863 5.3765 5.1098 1456858_at Gpr149 G protein-coupled receptor 149 BB075339 8.1215 3.0227 5.0988 1420514_at Tmem47 transmembrane protein 47 NM_138751 7.7663 2.7149 5.0513 1437453_s_at Pcsk9 proprotein convertase subtilisin/kexin type 9 AV010795 9.9135 4.8719 5.0416 1419639_at Efnb2 ephrin B2 U30244 7.8411 2.8013 5.0398 1449252_at Fam110c family with sequence similarity 110, member C NM_027828 8.8723 3.8342 5.0381 1418478_at Lmo1 LIM domain only 1 NM_057173 9.5234 4.4990 5.0244 insulin-like growth factor 2 mRNA binding 1455223_at Igf2bp1 BB794657 8.2848 3.2638 5.0211 protein 1 1460081_at Syt7 synaptotagmin VII AI854420 8.6567 3.6503 5.0064 1433474_at Edil3 EGF-like repeats and discoidin I-like domains 3 BB377340 8.7547 3.7571 4.9976 1459713_s_at Ano1 anoctamin 1, calcium activated chloride channel AU040576 10.3930 5.4108 4.9822 1425039_at Itgbl1 integrin, beta-like 1 BC020152 8.2458 3.2638 4.9820 calcium channel, voltage-dependent, 1440397_at Cacna2d1 BB464523 7.9091 2.9325 4.9766 alpha2/delta subunit 1 ST8 alpha-N-acetyl-neuraminide alpha-2,8- 1419186_a_at St8sia4 NM_009183 8.4201 3.4443 4.9759 sialyltransferase 4 1420380_at Ccl2 chemokine (C-C motif) ligand 2 AF065933 10.8318 5.8632 4.9686 1459679_s_at Myo1b myosin IB AA406997 9.6277 4.6674 4.9603 1429893_at Il17rd interleukin 17 receptor D AK012666 8.3971 3.4443 4.9529 nuclear receptor subfamily 2, group F, member 1416158_at Nr2f2 AI463873 7.3970 2.4513 4.9457 2 1440739_at Vegfc vascular endothelial growth factor C AW228853 7.7133 2.7705 4.9428 1416299_at Shcbp1 Shc SH2-domain binding protein 1 NM_011369 10.4914 5.5610 4.9304 1433795_at Tgfbr3 transforming growth factor, beta receptor III BM122301 9.5331 4.6127 4.9203 1422437_at Col5a2 collagen, type V, alpha 2 AV229424 9.2140 4.2966 4.9174
Load more

Recommended publications
  • Recombinant Human Carbonic Anhydrase XIII Protein Catalog Number: ATGP3059
    Recombinant human Carbonic Anhydrase XIII protein Catalog Number: ATGP3059 PRODUCT INPORMATION Expression system E.coli Domain 1-262aa UniProt No. Q8N1Q1 NCBI Accession No. NP_940986.1 Alternative Names Carbonic anhydrase 13, CAXIII PRODUCT SPECIFICATION Molecular Weight 31.8 kDa (285aa) confirmed by MALDI-TOF Concentration 0.5mg/ml (determined by Bradford assay) Formulation Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol, 1mM DTT Purity > 90% by SDS-PAGE Biological Activity Specific activity is > 2,500pmol/min/ug, and is defined as the amount of enzyme that hydrolyze 1.0pmole of 4- nitrophenyl acetate to 4-nitrophenol per minute at pH 7.5 at 37C. Tag His-Tag Application SDS-PAGE, Enzyme Activity Storage Condition Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles. BACKGROUND Description CA13 also known as carbonic anhydrase 13 belongs to the alpha-carbonic anhydrase family. The carbonic anhydrase from a family of enzymes that catalyze the rapid interconversion of carbon dioxide and water to bicarbonate and protons, a reversible reaction that occurs relatively slowly in the absence of catalyst. The active 1 Recombinant human Carbonic Anhydrase XIII protein Catalog Number: ATGP3059 site of most carbonic anhydrases contains a zinc ion; they are claasified as metalloenzymes. There are at least five distinct CA families (alpha, beta, gamma, delta, and epsilon). These families have no significant amino acid sequence similarity and in most cases are thought to be an example of convergent evolution. The alpha-CAs are found in humans.
    [Show full text]
  • Implications in Parkinson's Disease
    Journal of Clinical Medicine Review Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson’s Disease Silvia Paciotti 1,2 , Elisabetta Albi 3 , Lucilla Parnetti 1 and Tommaso Beccari 3,* 1 Laboratory of Clinical Neurochemistry, Department of Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy; [email protected] (S.P.); [email protected] (L.P.) 2 Section of Physiology and Biochemistry, Department of Experimental Medicine, University of Perugia, Sant’Andrea delle Fratte, 06132 Perugia, Italy 3 Department of Pharmaceutical Sciences, University of Perugia, Via Fabretti, 06123 Perugia, Italy; [email protected] * Correspondence: [email protected] Received: 29 January 2020; Accepted: 20 February 2020; Published: 21 February 2020 Abstract: Ceramides are a family of bioactive lipids belonging to the class of sphingolipids. Sphingolipidoses are a group of inherited genetic diseases characterized by the unmetabolized sphingolipids and the consequent reduction of ceramide pool in lysosomes. Sphingolipidoses include several disorders as Sandhoff disease, Fabry disease, Gaucher disease, metachromatic leukodystrophy, Krabbe disease, Niemann Pick disease, Farber disease, and GM2 gangliosidosis. In sphingolipidosis, lysosomal lipid storage occurs in both the central nervous system and visceral tissues, and central nervous system pathology is a common hallmark for all of them. Parkinson’s disease, the most common neurodegenerative movement disorder, is characterized by the accumulation and aggregation of misfolded α-synuclein that seem associated to some lysosomal disorders, in particular Gaucher disease. This review provides evidence into the role of ceramide metabolism in the pathophysiology of lysosomes, highlighting the more recent findings on its involvement in Parkinson’s disease. Keywords: ceramide metabolism; Parkinson’s disease; α-synuclein; GBA; GLA; HEX A-B; GALC; ASAH1; SMPD1; ARSA * Correspondence [email protected] 1.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Supplementary Table S1. Upregulated Genes Differentially
    Supplementary Table S1. Upregulated genes differentially expressed in athletes (p < 0.05 and 1.3-fold change) Gene Symbol p Value Fold Change 221051_s_at NMRK2 0.01 2.38 236518_at CCDC183 0.00 2.05 218804_at ANO1 0.00 2.05 234675_x_at 0.01 2.02 207076_s_at ASS1 0.00 1.85 209135_at ASPH 0.02 1.81 228434_at BTNL9 0.03 1.81 229985_at BTNL9 0.01 1.79 215795_at MYH7B 0.01 1.78 217979_at TSPAN13 0.01 1.77 230992_at BTNL9 0.01 1.75 226884_at LRRN1 0.03 1.74 220039_s_at CDKAL1 0.01 1.73 236520_at 0.02 1.72 219895_at TMEM255A 0.04 1.72 201030_x_at LDHB 0.00 1.69 233824_at 0.00 1.69 232257_s_at 0.05 1.67 236359_at SCN4B 0.04 1.64 242868_at 0.00 1.63 1557286_at 0.01 1.63 202780_at OXCT1 0.01 1.63 1556542_a_at 0.04 1.63 209992_at PFKFB2 0.04 1.63 205247_at NOTCH4 0.01 1.62 1554182_at TRIM73///TRIM74 0.00 1.61 232892_at MIR1-1HG 0.02 1.61 204726_at CDH13 0.01 1.6 1561167_at 0.01 1.6 1565821_at 0.01 1.6 210169_at SEC14L5 0.01 1.6 236963_at 0.02 1.6 1552880_at SEC16B 0.02 1.6 235228_at CCDC85A 0.02 1.6 1568623_a_at SLC35E4 0.00 1.59 204844_at ENPEP 0.00 1.59 1552256_a_at SCARB1 0.02 1.59 1557283_a_at ZNF519 0.02 1.59 1557293_at LINC00969 0.03 1.59 231644_at 0.01 1.58 228115_at GAREM1 0.01 1.58 223687_s_at LY6K 0.02 1.58 231779_at IRAK2 0.03 1.58 243332_at LOC105379610 0.04 1.58 232118_at 0.01 1.57 203423_at RBP1 0.02 1.57 AMY1A///AMY1B///AMY1C///AMY2A///AMY2B// 208498_s_at 0.03 1.57 /AMYP1 237154_at LOC101930114 0.00 1.56 1559691_at 0.01 1.56 243481_at RHOJ 0.03 1.56 238834_at MYLK3 0.01 1.55 213438_at NFASC 0.02 1.55 242290_at TACC1 0.04 1.55 ANKRD20A1///ANKRD20A12P///ANKRD20A2///
    [Show full text]
  • A Genome-Wide Association Study of Body Mass Index
    International Journal of Epidemiology, 2015, 700–712 doi: 10.1093/ije/dyv077 Advance Access Publication Date: 7 May 2015 Original article Genetic Epidemiology A genome-wide association study of body mass index across early life and childhood Nicole M Warrington,1,2* Laura D Howe,3,4* Lavinia Paternoster,3,4 Marika Kaakinen,5,6,7 Sauli Herrala,6 Ville Huikari,6 Yan Yan Wu,8 Downloaded from John P Kemp,2,3 Nicholas J Timpson,3,4 Beate St Pourcain,3,4 George Davey Smith,3,4 Kate Tilling,3,4 Marjo-Riitta Jarvelin,5,6,9,10,11 Craig E Pennell,1 David M Evans,2,3,4 Debbie A Lawlor,3,4 Laurent Briollais8,† and Lyle J Palmer12,† http://ije.oxfordjournals.org/ 1School of Women’s and Infants’ Health, University of Western Australia, Perth, WA, Australia, 2University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia, 3MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK, 4School of Social and Community Medicine, University of Bristol, Bristol, UK, 5Biocenter Oulu, and 6Institute of Health Sciences, University of Oulu, Oulu, Finland, 7Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, UK, 8Lunenfeld-Tanenbaum Research Institute, Mount 9 Sinai Hospital, Toronto, ON, Canada, Department of Children and Young People and Families, National at MPI Psycholinguistics on September 22, 2015 Institute for Health and Welfare, Oulu, Finland, 10Department of Epidemiology and Biostatistics, MRC- HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, UK, 11Unit of Primary Care, Oulu University Hospital, Oulu, Finland and 12The Joanna Briggs Institute, The Robinson Research Institute, and School of Translational Health Science, University of Adelaide, Adelaide, SA, Australia *Corresponding authors.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
    Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Differential Proteomic Analysis of the Pancreas of Diabetic Db/Db Mice Reveals the Proteins Involved in the Development of Complications of Diabetes Mellitus
    Int. J. Mol. Sci. 2014, 15, 9579-9593; doi:10.3390/ijms15069579 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Differential Proteomic Analysis of the Pancreas of Diabetic db/db Mice Reveals the Proteins Involved in the Development of Complications of Diabetes Mellitus Victoriano Pérez-Vázquez 1,*, Juan M. Guzmán-Flores 1, Daniela Mares-Álvarez 1, Magdalena Hernández-Ortiz 2, Maciste H. Macías-Cervantes 1, Joel Ramírez-Emiliano 1 and Sergio Encarnación-Guevara 2 1 Depto. de Ciencias Médicas, División de Ciencias de la Salud, Campus León, Universidad de Guanajuato, León, Guanajuato 37320, Mexico; E-Mails: [email protected] (J.M.G.-F.); [email protected] (D.M.-A.); [email protected] (M.H.M.-C.); [email protected] (J.R.-E.) 2 Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos 62210, Mexico; E-Mails: [email protected] (M.H.-O.); [email protected] (S.E.-G.) * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +52-477-7143-812; Fax: +52-477-7167-623. Received: 4 April 2014; in revised form: 14 May 2014 / Accepted: 19 May 2014 / Published: 30 May 2014 Abstract: Type 2 diabetes mellitus is characterized by hyperglycemia and insulin-resistance. Diabetes results from pancreatic inability to secrete the insulin needed to overcome this resistance. We analyzed the protein profile from the pancreas of ten-week old diabetic db/db and wild type mice through proteomics. Pancreatic proteins were separated in two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and significant changes in db/db mice respect to wild type mice were observed in 27 proteins.
    [Show full text]
  • The Role of High Density Lipoprotein Compositional and Functional Heterogeneity in Metabolic Disease
    The role of high density lipoprotein compositional and functional heterogeneity in metabolic disease By Scott M. Gordon B.S. State University of New York College at Brockport October, 2012 A Dissertation Presented to the Faculty of The University of Cincinnati College of Medicine in partial fulfillment of the requirements for the Degree of Doctor of Philosophy from the Pathobiology and Molecular Medicine graduate program W. Sean Davidson Ph.D. (Chair) David Askew Ph.D. Professor and Thesis Chair Professor Department of Pathology Department of Pathology University of Cincinnati University of Cincinnati Francis McCormack M.D. Gangani Silva Ph.D. Professor Assistant Professor Department of Pathology Department of Pathology University of Cincinnati University of Cincinnati Jason Lu Ph.D. Assistant Professor Division of Bioinformatics Cincinnati Children’s Hospital i Abstract High density lipoproteins (HDL) are complexes of phospholipid, cholesterol and protein that circulate in the blood. Epidemiological studies have demonstrated a strong inverse correlation between plasma levels of HDL associated cholesterol (HDL-C) and the incidence of cardiovascular disease (CVD). Clinically, HDL-C is often measured and used in combination with low density lipoprotein cholesterol (LDL-C) to assess overall cardiovascular health. HDL have been shown to possess a wide variety of functional attributes which likely contribute to this protection including anti-inflammatory and anti- oxidative properties and the ability to remove excess cholesterol from peripheral tissues and deliver it to the liver for excretion, a process known as reverse cholesterol transport. This functional diversity might be explained by the complexity of HDL composition. Recent studies have taken advantage of advances in mass spectrometry technologies to characterize the proteome of total HDL finding that over 50 different proteins can associate with these particles.
    [Show full text]
  • ONLINE SUPPLEMENTARY TABLE Table 2. Differentially Expressed
    ONLINE SUPPLEMENTARY TABLE Table 2. Differentially Expressed Probe Sets in Livers of GK Rats. A. Immune/Inflammatory (67 probe sets, 63 genes) Age Strain Probe ID Gene Name Symbol Accession Gene Function 5 WKY 1398390_at small inducible cytokine B13 precursor Cxcl13 AA892854 chemokine activity; lymph node development 5 WKY 1389581_at interleukin 33 Il33 BF390510 cytokine activity 5 WKY *1373970_at interleukin 33 Il33 AI716248 cytokine activity 5 WKY 1369171_at macrophage stimulating 1 (hepatocyte growth factor-like) Mst1; E2F2 NM_024352 serine-throenine kinase; tumor suppression 5 WKY 1388071_x_at major histocompatability antigen Mhc M24024 antigen processing and presentation 5 WKY 1385465_at sialic acid binding Ig-like lectin 5 Siglec5 BG379188 sialic acid-recognizing receptor 5 WKY 1393108_at major histocompatability antigen Mhc BM387813 antigen processing and presentation 5 WKY 1388202_at major histocompatability antigen Mhc BI395698 antigen processing and presentation 5 WKY 1371171_at major histocompatability antigen Mhc M10094 antigen processing and presentation 5 WKY 1370382_at major histocompatability antigen Mhc BI279526 antigen processing and presentation 5 WKY 1371033_at major histocompatability antigen Mhc AI715202 antigen processing and presentation 5 WKY 1383991_at leucine rich repeat containing 8 family, member E Lrrc8e BE096426 proliferation and activation of lymphocytes and monocytes. 5 WKY 1383046_at complement component factor H Cfh; Fh AA957258 regulation of complement cascade 4 WKY 1369522_a_at CD244 natural killer
    [Show full text]
  • Research Article Characterization of the Equine Skeletal Muscle
    McGivney et al. BMC Genomics 2010, 11:398 http://www.biomedcentral.com/1471-2164/11/398 RESEARCH ARTICLE Open Access CharacterizationResearch article of the equine skeletal muscle transcriptome identifies novel functional responses to exercise training Beatrice A McGivney1, Paul A McGettigan1, John A Browne1, Alexander CO Evans1,3, Rita G Fonseca2, Brendan J Loftus3, Amanda Lohan3, David E MacHugh1,3, Barbara A Murphy1, Lisa M Katz2 and Emmeline W Hill*1 Abstract Background: Digital gene expression profiling was used to characterize the assembly of genes expressed in equine skeletal muscle and to identify the subset of genes that were differentially expressed following a ten-month period of exercise training. The study cohort comprised seven Thoroughbred racehorses from a single training yard. Skeletal muscle biopsies were collected at rest from the gluteus medius at two time points: T1 - untrained, (9 ± 0.5 months old) and T2 - trained (20 ± 0.7 months old). Results: The most abundant mRNA transcripts in the muscle transcriptome were those involved in muscle contraction, aerobic respiration and mitochondrial function. A previously unreported over-representation of genes related to RNA processing, the stress response and proteolysis was observed. Following training 92 tags were differentially expressed of which 74 were annotated. Sixteen genes showed increased expression, including the mitochondrial genes ACADVL, MRPS21 and SLC25A29 encoded by the nuclear genome. Among the 58 genes with decreased expression, MSTN, a negative regulator of muscle growth, had the greatest decrease. Functional analysis of all expressed genes using FatiScan revealed an asymmetric distribution of 482 Gene Ontology (GO) groups and 18 KEGG pathways.
    [Show full text]